Sanofi touts whooping cough vaccine

Sanofi Pasteur is touting a new study of its whopping cough vaccine which shows it is safe and effective. Cases of whooping cough have been surging in the US, and Sanofi expects to get FDA approval for marketing the vaccine next month. The vaccine is already available in Canada. Sanofi says that Adacel is 83 percent effective in preventing whooping cough in adolescents and adults.  

- read this story from The Boston Globe

Suggested Articles

What the NASH field needs, says Genfit CEO Pascal Prigent, is something like the Hb1Ac test for diabetes.

Blocking a newly discovered molecule produced by B cells could slow their flow into the brain and offer a new way to treat MS, a Canadian team found.

The action will see Kiadis switch its attention to earlier-stage natural killer cell therapies against solid tumors and hematological cancers.